Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16.

Previous studies have shown that human papillomavirus (HPV) 16 E6 inhibits apoptosis induced during terminal differentiation of primary human keratinocytes (PHKs) triggered by serum and calcium. E6 inhibition of apoptosis was accompanied with prolonged expression of Bcl-2 and reduced elevation of Bax levels. In the present study, the effect of E6 on Bax mRNA expression and protein stability was investigated. These studies indicate that stable E6 expression in differentiating keratinocytes reduced the steady-state levels of Bax mRNA and shortened the half-life of Bax protein. These results were confirmed in transiently transfected 293T cells where E6 degraded Bax in a dose-dependent manner. Bax degradation was also exhibited in Saos-2 cells that lack p53, indicating its p53 independence. E6 did not form complexes with Bax and did not induce Bax degradation in vitro under experimental conditions where p53 was degraded. Finally, E6 aa 120-132 were shown to be necessary for Bax destabilization and, more importantly, for abrogating the ability of Bax to induce cellular apoptosis, highlighting the functional consequences of the E6-induced alterations in Bax expression.

[1]  E. Androphy,et al.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. , 1995, Science.

[2]  L. Sherman,et al.  Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat , 1988, Journal of virology.

[3]  K. Srivenugopal,et al.  The DNA repair protein, O6-Methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein , 2002, Oncogene.

[4]  John C Reed,et al.  Bcl-2 family proteins , 1998, Oncogene.

[5]  L. Banks,et al.  E3-Ubiquitin Ligase/E6-AP Links Multicopy Maintenance Protein 7 to the Ubiquitination Pathway by a Novel Motif, the L2G Box* , 1998, The Journal of Biological Chemistry.

[6]  T. McDonnell,et al.  Altered expression of bcl‐2 family member proteins in nonmelanoma skin cancer , 1999, Cancer.

[7]  Miranda Thomas,et al.  Inhibition of Bak-induced apoptosis by HPV-18 E6 , 1998, Oncogene.

[8]  M. Scheffner,et al.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.

[9]  Luca Scorrano,et al.  Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. , 2003, Biochemical and biophysical research communications.

[10]  T. Graf,et al.  Epstein-Barr Virus Encodes a Novel Homolog of the bcl-2 Oncogene That Inhibits Apoptosis and Associates with Bax and Bak , 1999, Journal of Virology.

[11]  A. Ciechanover,et al.  Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Veldman,et al.  Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 Oncoprotein , 2001, Journal of Virology.

[13]  L. Banks,et al.  The Human Papillomavirus E6 protein and its contribution to malignant progression , 2001, Oncogene.

[14]  M. Vidal,et al.  Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. , 1998, Genes & development.

[15]  H. zur Hausen,et al.  Papillomavirus infections--a major cause of human cancers. , 1996, Biochimica et biophysica acta.

[16]  Martin Scheffner,et al.  Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. , 2003, Seminars in cancer biology.

[17]  Goberdhan P Dimri,et al.  Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3 , 2002, Molecular and Cellular Biology.

[18]  S. Ōmura,et al.  mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  E. White,et al.  Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis , 1998, Oncogene.

[20]  John Calvin Reed,et al.  Bax cleavage is mediated by calpain during drug-induced apoptosis , 1998, Oncogene.

[21]  R. Schlegel,et al.  Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. , 1988, The EMBO journal.

[22]  M. Piacentini,et al.  Apoptosis in human skin development: Morphogenesis, periderm, and stem cells , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[23]  S. Korsmeyer,et al.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Kanda,et al.  Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein. , 1998, Biochemical and biophysical research communications.

[25]  R. Schlegel,et al.  Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16 , 1996, Journal of virology.

[26]  L. Banks,et al.  Multi-PDZ Domain Protein MUPP1 Is a Cellular Target for both Adenovirus E4-ORF1 and High-Risk Papillomavirus Type 18 E6 Oncoproteins , 2000, Journal of Virology.

[27]  Ajay Mahaputra Kumar,et al.  PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein* , 2000, The Journal of Biological Chemistry.

[28]  M Fujita,et al.  Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  John Calvin Reed,et al.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.

[30]  L. Laimins,et al.  Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites , 2001, Journal of Virology.

[31]  W. Zwerschke,et al.  Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. , 2000, Advances in cancer research.

[32]  John Calvin Reed,et al.  Bax is a transcriptional target and mediator of c-myc-induced apoptosis. , 2000, Cancer research.

[33]  M. O’Connor,et al.  The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300 , 1999, Journal of Virology.

[34]  P. Howley,et al.  The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Scheffner,et al.  Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53 , 1993, Molecular and cellular biology.

[36]  E. White,et al.  TNF-alpha signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. , 2000, Molecular cell.

[37]  A. Jackman,et al.  HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. , 1999, Virology.

[38]  Karl Münger,et al.  Human papillomavirus immortalization and transformation functions. , 2002, Virus research.

[39]  Q. Dou,et al.  Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Miranda Thomas,et al.  The role of the E6-p53 interaction in the molecular pathogenesis of HPV , 1999, Oncogene.

[41]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[42]  B. Dörken,et al.  Expression of the bcl‐2 gene family in normal and malignant breast tissue: Low bax‐α expression in tumor cells correlates with resistance towards apoptosis , 1995, International journal of cancer.

[43]  Miranda Thomas,et al.  Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins , 2000, Oncogene.

[44]  Helen Song,et al.  The Human Papillomavirus 16 E6 Protein Binds to Tumor Necrosis Factor (TNF) R1 and Protects Cells from TNF-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[45]  S. S. Lee,et al.  Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Galloway,et al.  E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc , 2001, Journal of Virology.

[47]  C. Sawyers,et al.  Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation , 2002, Oncogene.

[48]  S. Silverstein,et al.  Gps2, a Protein Partner for Human Papillomavirus E6 Proteins , 2001, Journal of Virology.

[49]  G. Núñez,et al.  Apoptosis in keratinocytes is not dependent on induction of differentiation. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[50]  P. Speight,et al.  Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. , 1996, European journal of cancer. Part B, Oral oncology.

[51]  G. Gao,et al.  N‐terminal cleavage of Bax by calpain generates a potent proapoptotic 18‐kDa fragment that promotes Bcl‐2‐independent cytochrome C release and apoptotic cell death , 2000, Journal of cellular biochemistry.

[52]  D. Patel,et al.  The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300 , 1999, The EMBO journal.

[53]  C. Dive,et al.  Mitochondrial membrane permeabilisation by Bax/Bak. , 2003, Biochemical and biophysical research communications.

[54]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[55]  B. Thomson,et al.  Viruses and apoptosis , 2001, International journal of experimental pathology.

[56]  G. Cohen,et al.  Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells , 2003, Oncogene.

[57]  Miranda Thomas,et al.  Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. , 1999, The Journal of general virology.

[58]  K. Noguchi,et al.  Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression: differential effects of Bcl-2 and Bcl-xL on Bax-induced caspase activation and apoptosis , 1997, Oncogene.

[59]  D. Wazer,et al.  The E6 Oncoproteins of High-Risk Papillomaviruses Bind to a Novel Putative GAP Protein, E6TP1, and Target It for Degradation , 1999, Molecular and Cellular Biology.

[60]  A. Jackman,et al.  Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation. , 1997, Virology.

[61]  L. Goldsmith,et al.  Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes , 1999, Experimental dermatology.

[62]  D. Lowy,et al.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.

[63]  J. Huibregtse,et al.  Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase , 2000, Molecular and Cellular Biology.

[64]  Shigeomi Shimizu,et al.  Bcl‐2 family: Life‐or‐death switch , 2000, FEBS letters.

[65]  H. Green,et al.  Structure and evolution of the human involucrin gene , 1986, Cell.

[66]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[67]  A. Jackman,et al.  Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP. , 2002, Virology.

[68]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[69]  M. Chalfie,et al.  Green fluorescent protein as a marker for gene expression. , 1994, Science.

[70]  T. Veldman,et al.  Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  F. Cope,et al.  Apoptosis II: The Molecular Basis of Apoptosis in Disease , 1994 .

[72]  M. Vu,et al.  Proteasomes Modulate Balance Among Proapoptotic and Antiapoptotic Bcl-2 Family Members and Compromise Functioning of the Electron Transport Chain in Leukemic Cells1 , 2001, The Journal of Immunology.